Despite its popularity, a new meta-analysis shows that CBD provides no meaningful benefit for patients with psychosis. Scientists note the treatment is well-tolerated but fails to outperform placebos in managing hallucinations, delusions, or cognitive issues.
Read moreDetailsA new review of nearly 50 studies suggests classic psychedelics like psilocybin and LSD can cause lasting personality changes. Research links the use of these substances to long-term increases in openness and significant drops in neuroticism.
Read moreDetailsA single dose of psilocybin reduces the drive to seek out rewards by increasing the activity of inhibitory brain cells. These findings help explain how psychedelics might induce long-lasting changes in brain circuits to treat substance use disorders.
Read moreDetailsPsilocybin could help patients with chronic cluster headaches sleep better, according to a recent study in the Journal of Psychopharmacology. Researchers also noted subtle shifts in brain microstructure that tend to accompany these improvements in rest.
Read moreDetailsA new study finds that children who start drinking alcohol before age 15 show distinct whole-brain network patterns years earlier. These brain features could serve as early markers for adolescent alcohol use vulnerability.
Read moreDetailsA new study suggests that the loss of protective sugar molecules drives premature aging and memory loss in people with HIV. In mice, common flu medications successfully preserved these sugars, offering a potential future approach to protect brain health.
Read moreDetailsA new study highlights how age and specific environments relate to drinking habits. Adapting to social norms is associated with higher alcohol use in youth, but linked to lower consumption among older adults in certain settings.
Read moreDetailsA new analysis of combined brain imaging data from 273 people reveals how classic psychedelics flatten the brain’s strict processing hierarchy, increasing communication between sensory systems and the cognitive regions responsible for abstract thought.
Read moreDetailsAfter years of severe decline, an 80-year-old woman with advanced Alzheimer’s temporarily regained her ability to speak, walk, and interact with family following a massive dose of psilocybin mushrooms, according to a striking new case report.
Read moreDetailsResearchers found that people currently taking popular metabolic drugs are less likely to act on aggressive impulses. The medications may help interrupt the neurological pathway from fleeting urges to violent actions.
Read moreDetailsPeople who regularly use psychedelic drugs outside of clinical settings process threatening facial expressions more efficiently than nonusers, according to recent brain imaging research. The scans reveal distinct neural habits that might explain the enduring emotional benefits of these substances.
Read moreDetailsA recent study in The Journal of Clinical Psychiatry suggests that a single dose of psilocybin, paired with psychological support, may rapidly and safely reduce chronic suicidal thoughts in adults with severe, treatment-resistant depression.
Read moreDetailsAdults with a history of childhood trauma who use psychedelics at raves or ceremonies may experience mental health improvements. New research suggests these communal settings are associated with reductions in PTSD symptoms and feelings of shame.
Read moreDetailsThe largest study to date on hallucinogen persisting perceptual disorder suggests the condition is closely tied to anxiety and functional somatic syndromes. Researchers hope these findings will pave the way for better, more targeted treatments.
Read moreDetailsA new study of drug-related fatalities suggests that having antidepressants actively circulating in the body is associated with a lower risk of death from MDMA, raising new questions for psychiatric researchers developing trauma therapies.
Read moreDetailsPsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)